4//SEC Filing
Kaye Mark 4
Accession 0001156039-25-000024
CIK 0001156039other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:44 PM ET
Size
8.9 KB
Accession
0001156039-25-000024
Insider Transaction Report
Form 4
Kaye Mark
EVP & CFO
Transactions
- Tax Payment
Common Stock
2025-03-03$395.50/sh−270$106,785→ 19,961 total - Award
Common Stock
2025-03-03+3,604→ 23,565 total - Award
Employee Stock Option (Right to Buy)
2025-03-03+13,713→ 13,713 totalExercise: $395.50Exp: 2035-03-03→ Common Stock (13,713 underlying)
Footnotes (4)
- [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- [F2]Represents restricted share units. Restrictions lapse as follows:1,201 shares each on 3/3/2026 and 3/3/2027, and 1,202 shares on 3/3/2028.
- [F3]Balance includes 17.59 shares acquired on December 20, 2024 through a dividend reinvestment plan.
- [F4]The option represents a right to purchase a total of 13,713 shares, and is exercisable in three annual installments of 4,571 shares each, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.
Documents
Issuer
Elevance Health, Inc.
CIK 0001156039
Entity typeother
Related Parties
1- filerCIK 0001748691
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:44 PM ET
- Size
- 8.9 KB